Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.

Author: BlanksteinRon, Di CarliMarcelo F, DorbalaSharmila, FormanDaniel E, HainerJon, LankaViswanatha, PartingtonSara L, SkaliHicham

Paper Details 
Original Abstract of the Article :
BACKGROUND: Regadenoson during exercise stress test (ETT) can provide maximal hyperemia for myocardial perfusion imaging (MPI), along with exercise information. Our aim was to study the feasibility and safety of regadenoson injection at peak ETT for submaximal heart rate (HR) response. METHODS: Con...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/22565239

データ提供:米国国立医学図書館(NLM)

Regadenoson: A Potential Solution for Suboptimal Heart Rate Response

Exercise stress testing is a valuable tool for evaluating cardiovascular health, but suboptimal heart rate response can limit its effectiveness. This study investigates the feasibility and safety of using regadenoson, a vasodilator, during exercise stress testing to enhance myocardial perfusion imaging (MPI) and obtain more comprehensive results.

Enhancing Exercise Stress Testing: A New Approach

The study demonstrates the safety and feasibility of administering regadenoson at peak exercise for patients with submaximal heart rate response. The results highlight the potential of this approach to improve the diagnostic accuracy of MPI and provide a more complete picture of cardiovascular function. It's like finding a hidden oasis in the desert of exercise stress testing, offering a more effective and informative approach to evaluating cardiovascular health.

Improving Cardiovascular Diagnostics

This research suggests that regadenoson administration during exercise stress testing can overcome the limitations of suboptimal heart rate response, enhancing the diagnostic accuracy of MPI and providing a more comprehensive assessment of cardiovascular function. This knowledge empowers healthcare professionals to make more informed decisions about patient care and optimize treatment strategies.

Dr. Camel's Conclusion

This study unveils the potential of regadenoson as a valuable tool for enhancing exercise stress testing, particularly in patients with suboptimal heart rate response. The research demonstrates the safety and feasibility of this approach, highlighting its potential to improve the diagnostic accuracy of MPI and provide a more comprehensive assessment of cardiovascular function. This research is like a beacon of hope in the desert of exercise stress testing, guiding us towards a more effective and informative approach to evaluating cardiovascular health.

Date :
  1. Date Completed 2012-12-27
  2. Date Revised 2021-10-21
Further Info :

Pubmed ID

22565239

DOI: Digital Object Identifier

NIHMS380513

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.